SGIOY
Price
$8.93
Change
+$0.03 (+0.34%)
Updated
Aug 15 closing price
Capitalization
15.19B
70 days until earnings call
TKPHF
Price
$29.45
Change
+$0.89 (+3.12%)
Updated
Aug 13 closing price
Capitalization
47.31B
Interact to see
Advertisement

SGIOY vs TKPHF

Header iconSGIOY vs TKPHF Comparison
Open Charts SGIOY vs TKPHFBanner chart's image
Shionogi & Co
Price$8.93
Change+$0.03 (+0.34%)
Volume$99.16K
Capitalization15.19B
Takeda Pharmaceutical
Price$29.45
Change+$0.89 (+3.12%)
Volume$1.33K
Capitalization47.31B
SGIOY vs TKPHF Comparison Chart in %
Loading...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOY vs. TKPHF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOY is a StrongBuy and TKPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (SGIOY: $8.93 vs. TKPHF: $29.45)
Brand notoriety: SGIOY and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SGIOY: 124% vs. TKPHF: 1%
Market capitalization -- SGIOY: $15.19B vs. TKPHF: $47.31B
SGIOY [@Pharmaceuticals: Generic] is valued at $15.19B. TKPHF’s [@Pharmaceuticals: Generic] market capitalization is $47.31B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOY’s FA Score shows that 2 FA rating(s) are green whileTKPHF’s FA Score has 2 green FA rating(s).

  • SGIOY’s FA Score: 2 green, 3 red.
  • TKPHF’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than TKPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOY’s TA Score shows that 5 TA indicator(s) are bullish while TKPHF’s TA Score has 7 bullish TA indicator(s).

  • SGIOY’s TA Score: 5 bullish, 3 bearish.
  • TKPHF’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, both SGIOY and TKPHF are a good buy in the short-term.

Price Growth

SGIOY (@Pharmaceuticals: Generic) experienced а -0.22% price change this week, while TKPHF (@Pharmaceuticals: Generic) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

SGIOY is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.3B) has a higher market cap than SGIOY($15.2B). TKPHF has higher P/E ratio than SGIOY: TKPHF (50.67) vs SGIOY (13.12). SGIOY YTD gains are higher at: 28.306 vs. TKPHF (10.093). TKPHF has higher annual earnings (EBITDA): 1.13T vs. SGIOY (206B). SGIOY has more cash in the bank: 576B vs. TKPHF (419B). SGIOY has less debt than TKPHF: SGIOY (11.7B) vs TKPHF (4.51T). TKPHF has higher revenues than SGIOY: TKPHF (4.48T) vs SGIOY (419B).
SGIOYTKPHFSGIOY / TKPHF
Capitalization15.2B47.3B32%
EBITDA206B1.13T18%
Gain YTD28.30610.093280%
P/E Ratio13.1250.6726%
Revenue419B4.48T9%
Total Cash576B419B137%
Total Debt11.7B4.51T0%
FUNDAMENTALS RATINGS
SGIOY vs TKPHF: Fundamental Ratings
SGIOY
TKPHF
OUTLOOK RATING
1..100
2532
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
288
PRICE GROWTH RATING
1..100
4447
P/E GROWTH RATING
1..100
4028
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is in the same range as SGIOY (20). This means that TKPHF’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's Profit vs Risk Rating (99) in the null industry is in the same range as TKPHF (100). This means that SGIOY’s stock grew similarly to TKPHF’s over the last 12 months.

SGIOY's SMR Rating (2) in the null industry is significantly better than the same rating for TKPHF (88). This means that SGIOY’s stock grew significantly faster than TKPHF’s over the last 12 months.

SGIOY's Price Growth Rating (44) in the null industry is in the same range as TKPHF (47). This means that SGIOY’s stock grew similarly to TKPHF’s over the last 12 months.

TKPHF's P/E Growth Rating (28) in the null industry is in the same range as SGIOY (40). This means that TKPHF’s stock grew similarly to SGIOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOYTKPHF
RSI
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
45%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
54%
MACD
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bullish Trend 3 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
42%
Advances
ODDS (%)
Bullish Trend 5 days ago
65%
Bullish Trend 18 days ago
39%
Declines
ODDS (%)
N/A
Bearish Trend 21 days ago
42%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
53%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 4 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOVR1.670.09
+5.70%
New Horizon Aircraft Ltd
FYBR37.110.03
+0.08%
Frontier Communications Parent
ANSCU11.64N/A
N/A
Agriculture & Natural Solutions Acquisition Corp
CAN0.77-0.01
-0.73%
Canaan
BCRX8.37-0.08
-0.95%
BioCryst Pharmaceuticals

SGIOY and

Correlation & Price change

A.I.dvisor tells us that SGIOY and ANIP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOY and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
+0.34%
ANIP - SGIOY
22%
Poorly correlated
-2.81%
EOLS - SGIOY
21%
Poorly correlated
+5.16%
TAK - SGIOY
20%
Poorly correlated
+1.35%
TKPHF - SGIOY
9%
Poorly correlated
N/A
ROMJF - SGIOY
8%
Poorly correlated
-2.03%
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TCNNF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TCNNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TCNNF - TKPHF
14%
Poorly correlated
-7.35%
VTRS - TKPHF
11%
Poorly correlated
-0.75%
SGIOY - TKPHF
9%
Poorly correlated
+0.34%
SFOSF - TKPHF
7%
Poorly correlated
N/A
RSCI - TKPHF
2%
Poorly correlated
N/A
More